Calcipotriene Impurity A-d4 |
|
Synonyms: (5E)-Calcipotriene-d4;(1S,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-(Cyclopropyl-d4)-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol; 5,6-trans-Calcipotriol-d4; PRI 2205-d4; (1a,3ß,5E,7E,22E,24S)-24-(Cyclopropyl-d4)-9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol; | |
Cat. No.: C10621 | CAS No.: |
MDL.: | Formula: C27H35D4O3 |
F.W.416.63 | Purity: 99% |
Storage: No Data Available | |
  |

Catalog Number: | C10621 | CAS No.: | ||
MDL: | Formula: | C27H35D4O3 | ||
F.W.: | 416.63 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | No Data Available | M.P.: | No Data Available | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | No Data Available | Stability: | No Data Available | |
Storage: | No Data Available | Category: | Reference Standard | |
Reference: | Wietrzyk, J. et al.: Anti-Cancer Drugs, 18, 447 (2007); Wietrzyk, J. et al.: Anticancer Res., 27, 3387 (2007); Filip, B. et al.: J. Ster. Biochem. Mol. Biol., 121, 399 (2010); | |||
Application: | The labelled trans-isomeric impurity of Calcipotriene and a vitamin D3 analogue with antitumor effects. | |||
Category: | Chiral Reagents, Impurities, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, |